Runzi Cheng

Runzi Cheng

Auto-generated profile, based on publicly available information

Runzi Cheng

Department of Gastrointestinal Surgery The First Affiliated Hospital of Shantou University Medical College Shantou 515041 China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2025 in Advanced Science
Verified
Journal Article
Open access
RCRunzi Cheng
Runzi Cheng
ZLZhenhao Li
Zhenhao Li
WLWeican Luo
Weican Luo
HCHongwu Chen
Hongwu Chen
TDTingting Deng
Tingting Deng
CHCong Huang
Cong Huang
Studies show that intracellular accumulation of copper ions causes cuproptosis, potentially enhancing anticancer immunity. However, the induction of cuproptosis inevitably faces challenges due to low intracellular copper deliver efficiency and collateral damage to normal tissues. This paper presents a self‐amplified cuproptosis nanoplatform (CEL NP) composed of Cu2−XS hollow nanospheres (HNSs), elesclomol (ES), and phase‐change material lauric acid (LA). Under NIR‐II laser irradiation, the photothermal energy generated by Cu2−XS HNSs melts LA, facilitating the precise release of ES and copper ions within the tumor microenvironment. Notably, ES can traverse the cell membrane and form ES‐Cu(II) complexes, thereby enhancing copper delivery within tumor cells. Excess Cu(II) also reacts with endogenous glutathione, reducing its inhibitory effect on cuproptosis. Ultimately, this amplified cuproptosis effect can activate immunogenic cell death, eliciting a robust immune response and promoting tumor suppression. The CEL NP‐mediated release of ES and copper ions offers a novel approach for anticancer therapy through cuproptosis induction.